United States · FDA National Drug Code directory

divalproex sodium

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
68788-4079_dbd1d178-77a3-46ff-985d-307dffaed1ad
Product NDC
68788-4079
Form
TABLET, DELAYED RELEASE
Composition / generic term
divalproex sodium
Labeler
Preferred Pharmaceuticals Inc.
Marketing category
ANDA
Marketing start / end (source format)
20260217
Source listing expiry
20271231

Source-listed ingredients

  • DIVALPROEX SODIUM — 250 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 TABLET, DELAYED RELEASE in 1 BOTTLE (68788-4079-3) · 68788-4079-3
  • 60 TABLET, DELAYED RELEASE in 1 BOTTLE (68788-4079-6) · 68788-4079-6
  • 90 TABLET, DELAYED RELEASE in 1 BOTTLE (68788-4079-9) · 68788-4079-9

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →